Data Integrity Inspections Go Global For Pharma
This article was originally published in SRA
Executive Summary
Data integrity inspections that have disrupted pharmaceutical exports from India to the US and Europe are spreading to exporters in China and other countries, as well as to domestic US and European manufacturers that may be unprepared for them.